CADL
Candel Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.78
−1.46%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-70.2%
Return on equity
-42.5%
Return on assets
-41.0%
Return on invested capital
0.00x
Asset turnover
-$56.0M
Cash from operations
$2.63
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026